Jubilant Pharmova Share Price
Small Cap | Pharmaceuticals and health care | NSE: JUBLPHARMA | BSE: 530019
₹929.20 -41.35 (-4.26 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 974.70
High (₹) 974.70
Low (₹) 910.70
Prev. Close (₹) 970.55
Volume 4,02,029
VWAP (₹) 894.40
ROCE (%) 6.08
Industry P/E 44.73
TTM P/E 23.60
P/B Ratio 2.71
Market Cap (₹) Cr.14,800.40
Dividend Yield (%)0.54
EPS (₹) 4.86
ROE1.42%
Sales Growth (%) 6.70
Profit Growth (%)-163.01
Day Range
974.70974.70
52 Week Range
570.051,309.00
Historical Returns
Returns (6M)
-14.2 %
Returns (1Y)
44.16 %
Returns (3Y)
99.74 %
Returns (5Y)
214.34 %
Returns (6M)
-14.2 %
Returns (1Y)
44.16 %
Returns (3Y)
99.74 %
Returns (5Y)
214.34 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Increasing Annual Revenue for Past 2 Years
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 45.51
MFI 43.58
ATR 52.14
Commodity Channel Index -183.70
ROC125 -1.98
ROC21 -5.69
Williams %R -84.24
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 920.79 | 938.87 | 960.24 | 899.42 | 881.34 | 859.97 | 841.89 |
Week Ago | 998.61 | 1,030.28 | 1,049.06 | 979.83 | 948.16 | 929.38 | 897.71 |
Month Ago | 916.01 | 950.08 | 986.96 | 879.13 | 845.06 | 808.18 | 774.11 |
EMA & SMA
929.20
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 943.04
9 Day 964.68
10 Day 953.82
12 Day 967.16
14 Day 969.70
20 Day 975.52
26 Day 961.39
50 Day 997.70
100 Day 1080.62
200 Day 961.87
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
EAST BRIDGE CAPITAL MASTER FUND LIMITED | block | Sell | 18 Mar, 2025 | ₹856.25 | 6,23,585 | NSE |
EAST BRIDGE CAPITAL MASTER FUND I LTD | block | Buy | 18 Mar, 2025 | ₹856.25 | 6,23,585 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 13 Sept, 2024 | ₹1,158.18 | 8,25,289 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 13 Sept, 2024 | ₹1,157.72 | 8,25,289 | NSE |
EAST BRIDGE CAPITAL MASTER FUND LIMITED | block | Sell | 05 Aug, 2024 | ₹851.00 | 14,05,000 | NSE |
EAST BRIDGE CAPITAL MASTER FUND I LTD | block | Buy | 05 Aug, 2024 | ₹851.00 | 14,05,000 | NSE |
EAST BRIDGE CAPITAL MASTER FUND LIMITED | bulk | Sell | 05 Aug, 2024 | ₹851.00 | 14,05,000 | NSE |
EAST BRIDGE CAPITAL MASTER FUND I LTD | bulk | Buy | 05 Aug, 2024 | ₹851.00 | 14,05,000 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 01 Aug, 2024 | ₹842.47 | 9,71,936 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 01 Aug, 2024 | ₹842.03 | 9,71,936 | NSE |
YESHA DEVELOPERS LLP | block | Sell | 26 Aug, 2021 | ₹617.00 | 2,50,000 | NSE |
KIFS DEALERS | block | Buy | 26 Aug, 2021 | ₹617.00 | 2,50,000 | NSE |
RARE ENTERPRISES | block | Sell | 25 Aug, 2021 | ₹594.35 | 5,00,000 | NSE |
REKHA RAKESH JHUNJHUNWALA | block | Buy | 25 Aug, 2021 | ₹594.35 | 5,00,000 | NSE |
JHUNJHUNWALA REKHA RAKESH | block | Buy | 25 Aug, 2021 | ₹594.35 | 20,00,000 | NSE |
JHUNJHUNWALA RAKESH RADHEYSHYAM | block | Buy | 25 Aug, 2021 | ₹594.35 | 25,00,000 | NSE |
RARE ENTERPRISES | bulk | Sell | 25 Aug, 2021 | ₹594.35 | 40,25,000 | NSE |
JHUNJHUNWALA REKHA RAKESH | bulk | Buy | 25 Aug, 2021 | ₹594.35 | 20,00,000 | NSE |
JHUNJHUNWALA RAKESH RADHEYSHYAM | bulk | Buy | 25 Aug, 2021 | ₹594.35 | 25,00,000 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
20 Sept, 2024 | Jubilant Employees Welfare Trust | Acquisition | ₹1,214.32 | 10,028 | NSE |
20 Sept, 2024 | Jubilant Employees Welfare Trust | Acquisition | ₹1,215.45 | 36,025 | NSE |
20 Sept, 2024 | Jubilant Employees Welfare Trust | Disposal | ₹1,219.60 | 3,542 | NSE |
17 Sept, 2024 | Jubilant Employees Welfare Trust | Disposal | ₹1,191.00 | 6,877 | NSE |
10 Sept, 2024 | Jubilant Employees Welfare Trust | Disposal | ₹937.70 | 18,045 | NSE |
05 Sept, 2024 | Jubilant Employees Welfare Trust | Disposal | ₹916.95 | 39,147 | NSE |
29 Aug, 2024 | JUBILANT EMPLOYEES WELFARE TRUST | Disposal | ₹902.70 | 1,576 | NSE |
20 Aug, 2024 | Jubilant Employees Welfare Trust | Disposal | ₹862.95 | 22,858 | NSE |
26 Jun, 2023 | Jubilant Employees Welfare Trust | Acquisition | ₹397.36 | 33,673 | NSE |
26 Jun, 2023 | Jubilant Employees Welfare Trust | Acquisition | ₹397.07 | 14,327 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
29 May, 2024 | Rs.5.0000 per share(500%)Final Dividend | 02 Aug, 2024 | 02 Aug, 2024 |
29 May, 2023 | Rs.5.0000 per share(500%)Final Dividend | 10 Aug, 2023 | 10 Aug, 2023 |
27 May, 2022 | Rs.5.0000 per share(500%)Final Dividend | 11 Aug, 2022 | 12 Aug, 2022 |
Announcements
Date | Source | Detail |
---|---|---|
02 Apr, 2025 | NSE India | Hari Shanker Bhartia Family Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
25 Mar, 2025 | NSE India | Jubilant Pharmova Limited has informed the Exchange about General Updates |
24 Mar, 2025 | NSE India | JUBILANT PHARMOVA LIMITED has informed the Exchange about Closure of Trading Window |
24 Mar, 2025 | NSE India | Jubilant Pharmova Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
20 Mar, 2025 | NSE India | Jubilant Pharmova Limited has informed the Exchange about General Updates - Jubilant Biosys Innovative Research Services Pte Limited, Singapore, has executedShareholders Agreement and other Transition Agreements with Pierre Fabre SA. |
12 Mar, 2025 | NSE India | Jubilant Pharmova Limited has informed the Exchange about General Updates |
12 Mar, 2025 | BSE India | Announcement under Regulation 30 - USFDA Report for Jubilant Cadista Pharmaceuticals INC., USA |
04 Mar, 2025 | NSE India | Jubilant Pharmova Limited has informed the Exchange about Transcript |
25 Feb, 2025 | NSE India | Jubilant Pharmova Limited has informed the Exchange about Rumour Verification - Regulation 30(11) |
25 Feb, 2025 | BSE India | Intimation under Regulation 30(11) |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 24 Jan, 2025 | 31 Jan, 2025 |
Quarterly Results | -- | 17 Oct, 2024 | 25 Oct, 2024 |
Quarterly Results | -- | 11 Jul, 2024 | 19 Jul, 2024 |
Audited Results & Final Dividend | -- | 23 May, 2024 | 29 May, 2024 |
Quarterly Results | -- | 24 Jan, 2024 | 02 Feb, 2024 |
Quarterly Results | -- | 20 Oct, 2023 | 27 Oct, 2023 |
Quarterly Results | -- | 30 Jun, 2023 | 19 Jul, 2023 |
Audited Results & Final Dividend | -- | 24 May, 2023 | 29 May, 2023 |
Quarterly Results | -- | 26 Jan, 2023 | 03 Feb, 2023 |
Quarterly Results | -- | 14 Oct, 2022 | 21 Oct, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 50.68% | 50.68% | 50.68% | 50.68% | 50.68% |
Foreign Institutions + | 16.96% | 20.29% | 23.38% | 23.18% | 25.73% |
Domestic Institutions + | 6.99% | 2.9% | 1.63% | 1.06% | 1.03% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 24.82% | 25.55% | 24.18% | 25.02% | 22.56% |
Others | 0.55% | 0.58% | 0.13% | 0.06% | 0% |
About Jubilant Pharmova
Jubilant Pharmova is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 784.70 Cr. and Equity Capital is Rs. 15.90 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Bhartia Group
Founded
1978
Managing Director
Mr. Priyavrat Bhartia
NSE Symbol
JUBLPHARMA
Jubilant Pharmova Management
Name | Designation |
---|---|
Mr. Shyam S Bhartia | Chairman |
Mr. Hari S Bhartia | Co-Chairman |
Mr. Priyavrat Bhartia | Managing Director |
Mr. Arjun Shanker Bhartia | Joint Managing Director |
Mr. Arvind Chokhany | WholeTime Director & Group CFO |
Dr. Ramakrishnan Arul | Whole Time Director |
Mr. Shirish G Belapure | Independent Director |
Mr. Sushil Kumar Roongta | Independent Director |
Mr. Vivek Mehra | Independent Director |
Mr. Arun Seth | Independent Director |
Dr. Harsh Mahajan | Independent Director |
Ms. Shivpriya Nanda | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Jubilant Pharmova
What is the share price of Jubilant Pharmova?
The share price of Jubilant Pharmova on 04 Apr, 2025 is ₹ 929.20.
What is 52W high and 52W low share price of Jubilant Pharmova?
The highest and lowest 52W share prices of Jubilant Pharmova are ₹ 1309.000 and ₹ 570.050
What is the market cap of Jubilant Pharmova?
The market capitalization of Jubilant Pharmova as of 04 Apr, 2025 is ₹ 14,800.40 Crores
What is the P/E ratio of Jubilant Pharmova?
The current P/E ratio of Jubilant Pharmova as of 04 Apr, 2025 is 44.73
What is the PB ratio of Jubilant Pharmova?
The PB ratio of Jubilant Pharmova as of 04 Apr, 2025 is 2.71
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)